Yin W, Wang Y, Wu Z, Ye Y, et al. Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study. Clin Cancer Res 2022 Jun 17. pii: 704938. doi: 10.1158/1078-0432.CCR-22-0446.
PMID: 35713517